---
title: "Nicotinic acid - Hypercholesterolemia"
sidebar: mydoc_sidebar
permalink: db00627-mesh-d006937-1.html
toc: false 
---


Path ID: `DB00627_MESH_D006937_1`
{% include image.html url="images/db00627-mesh-d006937-1.png" file="db00627-mesh-d006937-1.png" alt="db00627-mesh-d006937-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D009525 | Nicotinic acid | Drug |
| UniProt:O75907 | Diacylglycerol O-acyltransferase 2 (DGAT2) | Protein |
| REACT:R-HSA-75109 | Triglyceride biosynthesis | Pathway |
| MESH:D014280 | Triglyceride | ChemicalSubstance |
| MESH:D008076 | HDL Cholesterol | ChemicalSubstance |
| UniProt:P02647 | Apolipoprotein A1 | Protein |
| UniProt:P49019 | Hydroxycarboxylic acid receptor 3 | Protein |
| UniProt:Q86YN6 | PPARg coactivator-1b | Protein |
| MESH:D008074 | Lipoprotein | ChemicalSubstance |
| UniProt:P02656 | Apolipoprotein C3 | Protein |
| MESH:D005230 | Free fatty acids | ChemicalSubstance |
| MESH:D000242 | Cyclic AMP | ChemicalSubstance |
| UniProt:Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Protein |
| UniProt:P04114 | Apolipoprotein B | Protein |
| MESH:D008074 | Lipoprotein | ChemicalSubstance |
| MESH:D006937 | Hypercholesterolemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Nicotinic Acid | DECREASES ACTIVITY OF | Diacylglycerol O-Acyltransferase 2 (Dgat2) |
| Diacylglycerol O-Acyltransferase 2 (Dgat2) | NEGATIVELY REGULATES | Triglyceride Biosynthesis |
| Triglyceride Biosynthesis | DECREASES ABUNDANCE OF | Triglyceride |
| Nicotinic Acid | INCREASES ACTIVITY OF | Hydroxycarboxylic Acid Receptor 2 |
| Hydroxycarboxylic Acid Receptor 2 | DECREASES SYNTHESIS OF | Cyclic Amp |
| Cyclic Amp | DECREASES ABUNDANCE OF | Free Fatty Acids |
| Free Fatty Acids | DECREASES EXPRESSION OF | Apolipoprotein C3 |
| Apolipoprotein C3 | DECREASES SYNTHESIS OF | Lipoprotein |
| Free Fatty Acids | DECREASES EXPRESSION OF | Pparg Coactivator-1B |
| Pparg Coactivator-1B | DECREASES SYNTHESIS OF | Lipoprotein |
| Nicotinic Acid | INCREASES ACTIVITY OF | Hydroxycarboxylic Acid Receptor 3 |
| Hydroxycarboxylic Acid Receptor 3 | DECREASES SYNTHESIS OF | Cyclic Amp |
| Nicotinic Acid | DECREASES DEGRADATION OF | Apolipoprotein A1 |
| Apolipoprotein A1 | INCREASES ABUNDANCE OF | Hdl Cholesterol |
| Hdl Cholesterol | MANIFESTATION OF | Hypercholesterolemia |
| Triglyceride | INCREASES DEGRADATION OF | Apolipoprotein B |
| Apolipoprotein B | DECREASES SYNTHESIS OF | Lipoprotein |
| Lipoprotein | MANIFESTATION OF | Hypercholesterolemia |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00627#mechanism-of-action](https://go.drugbank.com/drugs/DB00627#mechanism-of-action){:target="_blank"}